Literature surveillance is a foundational pillar of Pharmacovigilance, yet it is becoming increasingly difficult for Life Sciences organisations to sustain using traditional, manual approaches. The exponential growth of global and local medical publications, rising regulatory expectations around local journal monitoring, and high duplication rates have significantly increased workload—while only a small fraction of retrieved articles ultimately yield reportable safety insights. As a result, teams face mounting pressure to scale operations, reduce cycle times, and improve signal detection without increasing compliance risk or operational cost.
WINGS PV is Wipro’s AI powered Literature Automation capability, designed to transform literature surveillance from a search heavy, manual process into an intelligent, insight driven workflow. Built using responsible, agentic AI and deeply rooted pharmacovigilance expertise, it embeds intelligence across screening, classification, prioritisation, and safety data extraction—while ensuring that medical judgement and oversight remain central at every stage.
Rather than replacing scientific review, the solution augments it. AI agents assist reviewers by filtering noise, deduplicating content, highlighting safety relevant information, and prioritising high risk publications for early attention. Human in the loop controls, full traceability, and audit ready workflows ensure alignment with GxP, CSV, and global regulatory expectations.
Delivered as part of the new WINGS PV platform it integrates seamlessly into existing safety ecosystems and supports modular adoption with minimal disruption. By combining precision led AI, orchestrated workflows, and compliance by design, it enables organisations to reduce manual effort, accelerate safety insights, and sustain inspection readiness—turning ever growing literature volume into actionable, trusted safety intelligence.
